Dr. Michael Farzan: Ace2, The Sars-Cov-2 S Protein, And Better Rbd-Based Vaccines

Dr. Michael Farzan: ACE2, the SARS-CoV-2 S protein, and better RBD-based vaccines

Human Immunome Project

In vitro and in vivo characterization of novel SARS-CoV-2 protein subunit vaccine

Promega and Arctoris webinar Screen for SARS-CoV-2 Spike RBD:ACE2 inhibitor interactions

Dr. James E. Crowe, Jr: Human Monoclonal Antibodies for SARS-CoV-2

Human Immunome Project

Addressing the Coronavirus Challenge: Front Row Lecture with Michael Farzan, PhD

Scripps Research

Vaccine targeting the RBD of S protein of SARS-COV-2 induces protective immunity

3-11-21 - Impact of SARS-CoV-2 spike protein variation on therapeutics and vaccines

WashU Med Department of Medicine

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor

Dr. Menno van Zelm: B cell memory to SARS-CoV2 Nucleocapsid and Spike proteins in COVID-19 disease

Human Immunome Project

Will SARS Cov-2 Become Resistant to Current Vaccines - Implications | Penny Moore, PhD

Academic Medical Education

SARS-CoV-2 Vaccines and Variants

The Rockefeller University

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic...

Dr. Dan Barouch: COVID-19 Vaccine Development

Human Immunome Project

Dr. Jesse Bloom: Interpreting the Evolution of SARS-CoV-2 in Context of Omicron

Human Immunome Project

Dr. Penny Moore: SARS-CoV-2 Infection and Vaccination in South Africa

Human Immunome Project

Dr. Barney S. Graham: Rapid COVID-19 Vaccine Development Enabled by Prototype Pathogen Preparedness

Human Immunome Project

Scripps Researcher Discusses Development of New Vaccine

WPTV News - FL Palm Beaches and Treasure Coast

COVID-19 Uptake is Enhanced by NRP-1

COVID-19 Symposium: Cellular Responses to SARS-CoV-2 | Dr. Michael Betts

Dr. Bette Korber: Spike mutations and recombination in SARS-CoV-2 pandemic viruses

Human Immunome Project